Expression of Cancer Stem Cell Marker CD44 in Oral Squamous Cell Carcinoma of Tongue by Anitha, J
 
 
 
 
 
ABSTRACT 
 
 
 
 
Background: Cancer Stem Cells are a small subpopulation of cancer cells that have 
ability of self-renewal and are potent to differentiate into progenitor cells.  CD44 is a 
Cancer Stem Cell marker which is involved in regulation of growth, survival, 
differentiation and migration through binding with growth factors.  Hence it serves as 
a prognostic tool in Oral Squamous Cell Carcinoma. 
 
 
Aim and objective: To evaluate the expression of CD44 in tissues of normal 
mucosa, Oral Squamous Cell Carcinoma of Tongue and Buccal Mucosa  and to  
correlate CD44 expression in different gradings of Oral Squamous Cell Carcinoma. 
 
Materials and methods:  To investigate CD44 expression in Formalin Fixed 
Paraffin Embedded tissues of normal mucosa (n=6), Oral Squamous Cell Carcinoma 
of Tongue (n=16) and Oral Squamous Cell Carcinoma of Buccal Mucosa (n=16) 
using mouse monoclonal CD44 primary antibody and SS Polymer HRP/DAB 
detection kit by Immunohistochemistry.  Tonsil serves as a positive control for 
CD44.  
 
  
 
 
 
 
 
 
Results: All the samples of our study were positive for CD44.  Normal mucosa 
exhibited strong staining and high percentage of CD44 positive cells.    When 
tumor sub-site was not taken into account, intensity and percentage of positive cells 
for CD44 increased with decreasing grades of histologic differentiation  in which 
intensity showed significant results (0.009*).  With regards to the sub-site, poorly 
differentiated tongue tumors exhibited weak staining and less percent of positive 
cells (11 to 24%) compared to that of the tumors of buccal mucosa. 
 
 
Conclusion: Staining intensity of CD44 was found to be an independent prognostic 
factor rather than the percentage of positive cells in Oral Squamous Cell 
Carcinoma.  CD44 proved to be an efficient biomarker in addressing the tumor 
aggressiveness and  poor outcome with respect to the sub-site, tongue. 
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